Sinisterra-Díaz Stiven Ernesto, Vasquez-Forero Diana Marcela, Ordoñez Laura, Prieto Luis Eduardo, Pachajoa Harry
Departamento de Genética Clínica, Fundación Valle del Lili, Cali, Colombia.
Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia.
Mol Syndromol. 2025 May;16(3):278-282. doi: 10.1159/000541654. Epub 2024 Oct 31.
syndrome is a neurodevelopmental disease caused by de novo pathogenic variants in encoding the purine-binding element alpha protein. It is characterized by autosomal dominant inheritance and a heterogeneous phenotype.
We describe a 7-year-old patient with history of congenital pneumonia, accompanied by hypotonia, convulsive episodes, poor sucking ability, neurodevelopmental delay. Physical examination revealed some dysmorphic features. Molecular analysis identified a de novo, heterozygous variant in (NM_005859.5): c.692T>C; p.Phe231Ser, which was classified as pathogenic.
In this report, we present a Colombian case of PURA syndrome. This case highlights the challenges associated with the early diagnosis of a newly described syndrome, in a limited-resources health system.
[疾病名称]综合征是一种由编码嘌呤结合元件α蛋白的基因发生新生致病性变异引起的神经发育疾病。其特征为常染色体显性遗传和异质性表型。
我们描述了一名7岁患者,有先天性肺炎病史,伴有肌张力减退、惊厥发作、吸吮能力差、神经发育迟缓。体格检查发现一些畸形特征。分子分析确定了[基因名称](NM_005859.5)中的一个新生杂合变异:c.692T>C;p.Phe231Ser,该变异被分类为致病性变异。
在本报告中,我们呈现了一例哥伦比亚的[疾病名称]综合征病例。该病例凸显了在资源有限的卫生系统中,对一种新描述综合征进行早期诊断所面临的挑战。